TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ZBIO

Zenas BioPharma, Inc.

Healthcare · Biotechnology

28.30$ +1.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Zenas BioPharma, Inc. (ZBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 702 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ZBIO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
84 68 49 200 403 370 334 293 322 384 748 702
77 60 40 189 394 356 318 279 297 351 730 654
72 57 37 184 360 320 197 44 116 111 500 197
72 57 37 184 387 351 312 273 291 343 717 643
– – – – – – – – – – 1.1 0.8
286 294 302 39 44 58 49 53 126 141 412 455
16 23 30 39 44 57 49 53 52 63 61 66
0.6 0.6 0.5 0.5 0.4 0.8 0.9 0.8 0.6 1.1 1.0 0.8
2.3 5.4 8.8 8.4 15 17 20 7.9 6.4 7.1 8.9 7.6
20 20 21 – – – – – – – 266 297
-202 -226 -252 161 359 312 284 240 196 242 336 247
-206 -230 -258 -296 -335 -387 -421 -473 -525 -765 -846 -958
42 38 38 38 42 42 42 42 42 46 56 63

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?